Pregnancy-Lipid Effect & ASCVD Risk Management

Case Study: Pharmacotherapy for Dyslipidemia and Metabolic Dysfunction-Associated Steatotic Fatty Liver Disease

Clinical Case The patient is a 67-year-old white gentleman with type 2 diabetes mellitus (T2DM), hypertension (HTN), 20-pack-year smoking history, and dyslipidemia. He presented to…

So Which Guideline & Risk Scoring System Should I Use?

Pediatric Hypercholesterolemia

Novel Advancements in GLP-1 Receptor Agonist Treatment

Introduction Obesity is a complex, chronic medical condition. Although defined by a BMI >30 kg/m2, it is now understood to be much more than a…

The Intersection of Diabetes, Obesity, and Dyslipidemia

Introduction/Magnitude of The Problem Diabetes mellitus (DM) is a systemic disease of abnormal carbohydrate metabolism leading to chronic hyperglycemia. It is a major contributor to chronic…

The Lipid Panel – Polycystic Ovary Syndrome

Genetic Testing